Vaxart, Inc.
The company is developing oral tablet vaccines based on its proprietary oral vaccine platform. It will develop preventive vaccines for infectious diseases such as COVID-19 and norovirus, as well as therapeutic immuno-oncology vaccines targeting cervical cancer.
Overview
Overview | |
|---|---|
Country | United States |
State | California |
Employees | 109 |
Founded | |
Financials | |
|---|---|
Market Capitalization | 152.44M |
Revenue | 8.88M |
Operating Income | -81.84M |
Operating Margin | -921.16% |
Net Income | -81.74M |
Ranking
Operating Income
Operating Income Ranking | |
|---|---|
All | 4696 / 5373 |
Sector : Healthcare | 839 / 1144 |
Industry : Biotechnology | 411 / 645 |
Market Capitalization
Market Capitalization Ranking | |
|---|---|
All | 3812 / 5565 |
Sector : Healthcare | 639 / 1182 |
Industry : Biotechnology | 331 / 670 |
Net Income
Net Income Ranking | |
|---|---|
All | 4641 / 5436 |
Sector : Healthcare | 850 / 1164 |
Industry : Biotechnology | 432 / 659 |
Employees
Employees Ranking | |
|---|---|
All | 3956 / 5330 |
Sector : Healthcare | 610 / 1174 |
Industry : Biotechnology | 238 / 667 |